Vir Biotechnology, Inc. — Director's Dealing 2020

May 8, 2020

SEC Form 4/A — Form 4/A

Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2020-05-01

Reporting Person: MORE ROBERT J (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	70651	Direct

Footnotes

F1: This Form 4 amendment is being filed solely to update the reporting person's total shares directly beneficially owned following the transactions reported in the original Form 4 statement filed May 5, 2020 (the "Original Form 4"). Includes 28,287 shares received in a pro-rata distribution from Alta Partners NextGen Fund I, L.P. initiated on April 29, 2020. The Original Form 4 reported an estimated 29,170 shares to be received in such distribution because the exact number of shares had not been finalized as of the filing deadline for the Original Form 4.